Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of <i>NTRK1</i>
Matthew L. Hemming(University of Massachusetts Chan Medical School), Sandro Santagata(Harvard University), Monica M. Bertagnolli(National Institutes of Health), Karan Malik(Harvard University), Adrián Mariño‐Enríquez(Harvard University Press), Ewa Sicińska(Harvard University), Jyothi P. Jagannathan(Brigham and Women's Hospital), Jia‐Ren Lin(Harvard University), George D. Demetri(Dana-Farber Cancer Institute), Michael J. Nathenson(Harvard University), Peter K. Sorger(Harvard University Press), Ziming Du(Fuyang City People's Hospital), Shaolin Mei(Harvard University)
Cited by 36
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k